Search

Search Constraints

You searched for: Author/Creator Malorni, L

Search Results

2. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial. (11th June 2018)